Home / Street Sector / Stocks Breaking Stillness on Analysts Estimates: Fortinet Inc. (NASDAQ:FTNT), Teradyne Inc. (NYSE:TER)

Stocks Breaking Stillness on Analysts Estimates: Fortinet Inc. (NASDAQ:FTNT), Teradyne Inc. (NYSE:TER)

Fortinet Inc. (NASDAQ:FTNT) [Trend Analysis] knocking active thrust in leading trading session, shares a decrease of -2.77% to 31.64 with around 4.01 Million shares have changed hands in this session. Fundamentalist can give brighter side of a picture but an analyst can glow the darker parts stored in any investment.

Let us view how analysts have ranked FTNT in recent few months. In ratings table the FTNT given BUY ratings by 18 analysts in current phase and 2 analysts suggest it as overweight security. The 0 number of analyst/s have SELL recommendation for current month on FTNT. While 12 number of analysts gave ratings for HOLD in current. As per remarks given by WSJ, overall consensus pool recommend it as Overweight security.

The stock was assessed in terms of profitability as current quarter EPS estimate trends showed $0.21 at current month while compared with $0.28 in a month ago. The stock next year first quarter current estimate trend for EPS was for $0.15 and on annual basis FY 2016 estimate trends at current was for $0.64 as compared to one month ago of $0.70, and for next year per share earnings estimates have $0.81.

The stock is going forward its fifty-two week low with 36.61% and lagging behind from its 52-week high price with -15.58%. Similar, the positive performance for the quarter recorded as -9.34% and for the year was -7.05%, while the YTD performance remained at 1.51%. FTNT has Average True Range for 14 days of 1.05.

Teradyne Inc. (NYSE:TER) [Trend Analysis] retains strong position in active trade, as shares scoring 0.86% to $24.68 in a active trade session, while looking at the shares volume, around 1.49 Million shares have changed hands in this session.

The TER held a rough session during the week but was ready to get some critical analysis. The stock was assessed by a pool of analysts at WSJ and came out with some serious outcomes not to be avoided before making investment. The TER ratings chart showed that 7 gave HOLD ratings for the current month as 0 analysts opting for Overweight option for same period, whereas, 1 analyst out of pool gave UNDERWEIGHT rating. For stocks’ current month, 7 analysts opted for BUY ratings. The stock price target chart showed average price target of 24.42 as compared to current price of 24.68.

Taking look on per share earnings estimates, its next year first quarter current estimate trend for EPS was for $0.30 and on annual basis FY 2016 estimate trends at current was for $1.41 as compared to one month ago of $1.26, and for next year per share earnings estimates have $1.53.

The firm has institutional ownership of 95.70%, while insider ownership included 0.20%. TER attains analyst recommendation of 2.40 with week’s performance of 5.47%. Investors looking further ahead will note that the Price to next year’s EPS is 8.29%.

 

About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Check Also

Stocks Luring Investors with Juicy Profitability: Crown Castle International (NYSE:CCI), GoDaddy (NYSE:GDDY)

Crown Castle International Corp. (NYSE:CCI) runs in leading trade, it are increasing 0.31% to traded …

Leave a Reply

Your email address will not be published. Required fields are marked *